Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2019 Sep 17.

Published in final edited form as: Int J Radiat Biol. 2019 Jan 7;95(3):338–346. doi: 10.1080/09553002.2019.1554920

Table 1.

Quantification of tumor size, new tumor incidence, ADC, K_trans, and tumor-enhancing fraction.

						ADC (×10⁻³ mm²/sec)
		Tumors per Animal	Tumor Size (mm³)	New Tumors (%)	Enhancing Fraction	Tumor	Contralateral	K_trans (min⁻¹)
Sham	Pre	16.8 ±9.4	0.28 ±0.22		0.49±0.08	0.75 ± 0.01	0.65 ±0.06	0.050± 0.005
	Post	22.8 ± 11.8	0.44 ±0.31^**	41.5 ±29.2	0.62 ±0.05^*	0.77 ± 0.02	0.64±0.09	0.056± 0.003
WBRT	Pre	17.4 ±11.7	0.23 ±0.12		0.46±0.08	0.75 ± 0.02	0.64±0.05	0.048± 0.005
	Post	20.4 ± 13.2	0.34 ± 0.21^**^,#	20.7 ±16.1	0.71 ±0.04^*	0.83 ±0.02^*^,#	0.65 ±0.07	0.073 ± 0.007^*^,#

^*

p < .05.

^**

p < .01 compared to pre-treatment.

^#

p < .05 compared to sham group post-treatment.